GJA1 and chronic kidney disease: Whilst our work shows that targeting Cx43 hemichannels prevents the severity of tubulointerstitial fibrosis that develops in UUO mice, future studies are required to determine the efficacy of Peptide5 or alternative Cx43 hemichannel blockers in other models of CKD notably those where full renal function can be assessed.